Horizon Therapeutics PLC
NASDAQ:HZNP
Revenue Breakdown
Breakdown by Geography
Horizon Therapeutics PLC
Total Revenue:
3.6B
USD
|
United States:
3.6B
USD
|
Non-Us:
39.5m
USD
|
Breakdown by Segments
Horizon Therapeutics PLC
Total Revenue:
3.6B
USD
|
Tepezza:
2B
USD
|
Krystexxa:
716.2m
USD
|
Ravicti:
325.7m
USD
|
Procysbi Developed Technology:
210m
USD
|
Uplizna:
154.6m
USD
|
Actimmune:
126.1m
USD
|
Pennsaid 2%:
73.8m
USD
|
Rayos:
41.9m
USD
|
Buphenyl:
7.3m
USD
|
Duexis:
4.9m
USD
|
Vimovo:
1.9m
USD
|
Quinsair:
1.1m
USD
|